EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Common Brain Protein and Genetic Loci Between Parkinson's Disease and Lewy Body Dementia

Tingting Jia, Fuhua Yang, Fengqin Qin, Yongji He, Feng Han, Chengcheng Zhang iD

CNS Neuroscience & Therapeutics · 2025-04 · 31 (4)

DOI: 10.1111/cns.70370 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 09.04.2025. Verfasst von Tingting Jia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Mental Health Center and Psychiatric Laboratory, the State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, Sichuan,…. Hauptthemen laut MEDLINE: Lewy Body Disease, Parkinson Disease, Brain, Nerve Tissue Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, Postdoctoral Foundation of West China Hospital, Key R & D projects of Science and Technology Department of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson's disease (PD) and Lewy body dementia (LBD) have many common features, including clinical manifestations, neurochemistry, and pathology, but little is known about their shared brain proteins and genetic factors.

Methods

To identify susceptibility‐related brain proteins that are shared between PD and LBD patients, proteome‐wide association studies (PWASs) were conducted by integrating human brain protein quantitative trait loci (pQTLs) with large‐scale genome‐wide association studies (GWASs) of both diseases. Subsequently, pleiotropy‐informed conditional false discovery rate (pleioFDR) analysis was performed to identify common risk genetic loci between PD and LBD. Finally, the downregulation of these risk genes in different disease states was validated by differential gene expression analysis.

Results

PWASs identified 12 PD risk proteins and nine LBD risk proteins, among which TMEM175 ( z PD = −7.25, P PD = 4.12E‐13; z LBD = −6.02, P LBD = 1.75E‐09) and DOC2A ( z PD = −4.13, P PD = 3.71E‐05; z LBD = −3.91, P LBD = 9.08E‐05) were shared. PleioFDR analysis revealed that five genetic risk loci mapped to eight genes associated with PD and LBD, including the proteome‐wide significant risk gene TMEM175 (ConjFDR = 5.74E‐03). Differential expression analysis verified that TMEM175 was significantly downregulated in the midbrains of PD patients ( p = 1.19E‐02), and further exploration revealed that TMEM175 was also dramatically downregulated in the substantia nigra of PD patients ( p = 1.16E‐02) and incidental Lewy body disease patients ( p = 7.52E‐03). Moreover, TMEM175 was significantly downregulated in induced pluripotent stem cell‐derived dopaminergic neurons from PD patients ( p = 4.60E‐02).

Conclusion

Dysregulation of TMEM175 may confer PD and LBD risk and may be partly responsible for their comorbidity. Our results revealed the common genetic risk factors between PD and LBD, which elucidated the shared genetic basis of these diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lewy Body DiseaseParkinson DiseaseBrainNerve Tissue ProteinsGenetic LociHumansGenome-Wide Association StudyGenetic Predisposition to DiseaseQuantitative Trait LociMaleFemaleAged

Stichwörter der Autor:innen

dementiaprotein quantitative trait lociproteome‐wide association studyrisk gene

Substanzen

Nerve Tissue Proteins

Autor:innen und Institutionen

  • Mental Health Center and Psychiatric Laboratory, the State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Department of Gastroenterology and Hepatology and Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Department of Nephrology, The Sixth People's Hospital of Chengdu, Chengdu, Sichuan, China.
  • Department of Neurology, The 3rd Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
  • Clinical Trial Center, National Medical Products Administration key Laboratory for Clinical Research and Evaluation of Innovative Drugs, West China Hospital Sichuan University, Chengdu, China.
  • Department of Emergency Medicine, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, China.

ORCID-Profile: Chengcheng Zhang

Förderung

  • China Postdoctoral Science Foundation
  • Postdoctoral Foundation of West China Hospital
  • Key R & D projects of Science and Technology Department of Sichuan Province

Zitieren

APA

Jia, T., Yang, F., Qin, F., He, Y., Han, F., & Zhang, C. (2025). Identification of Common Brain Protein and Genetic Loci Between Parkinson's Disease and Lewy Body Dementia. CNS Neuroscience & Therapeutics, 31(4). https://doi.org/10.1111/cns.70370

Vancouver

Jia T, Yang F, Qin F, He Y, Han F, Zhang C. Identification of Common Brain Protein and Genetic Loci Between Parkinson's Disease and Lewy Body Dementia. CNS Neuroscience & Therapeutics. 2025;31(4). doi:10.1111/cns.70370

BibTeX
@article{Jia2025,
  author = {Jia, Tingting and Yang, Fuhua and Qin, Fengqin and He, Yongji and Han, Feng and Zhang, Chengcheng},
  title = {Identification of Common Brain Protein and Genetic Loci Between Parkinson's Disease and Lewy Body Dementia},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2025},
  volume = {31},
  number = {4},
  doi = {10.1111/cns.70370}
}
Kostenlos starten →